고혈압 및 동반 고콜레스테롤혈증 환자에서 QCZ484와 인클리시란 조합의 약력학 평가

This is a multicenter, randomized, double-blind, factorial design Phase 2 study to evaluate the pharmacodynamics, safety and tolerability of a combination of QCZ484 and inclisiran compared to QCZ484, inclisiran, and placebo in participants with hypertension and concomitant hypercholesterolemia.